NCT05372224View on ClinicalTrials.gov

Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

June 22, 2021

Study Completion Date

June 22, 2021

Conditions
Hypovitaminosis DOsteoporosis, PostmenopausalMenopause
Interventions
DRUG

Cholecalciferol

4000 IU were administrated once a day for 3 months.

Trial Locations (1)

07300

Patricia Loranca-Moreno, Mexico City

All Listed Sponsors
collaborator

Universidad Nacional Autonoma de Mexico

OTHER

collaborator

National Polytechnic Institute, Mexico

OTHER

lead

Hospital Regional 1o de Octubre

OTHER

NCT05372224 - Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis | Biotech Hunter | Biotech Hunter